The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Methotrexate 10 mg tablets

10 milligram(s) Tablet

Morningside Healthcare LtdPA1333/009/001

Main Information

Trade NameMethotrexate 10 mg tablets
Active SubstancesMethotrexate
Strength10 milligram(s)
Dosage FormTablet
Licence HolderMorningside Healthcare Ltd
Licence NumberPA1333/009/001

Group Information

ATC CodeL04AX Other immunosuppressants
L04AX03 methotrexate

Status

Authorised/WithdrawnAuthorised
Licence Issued21/03/2011
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListMethotrexate 10mg Tablets
Interchangeable List CodeIC0098-002-002
Interchangeable List DocumentPDF of Interchangeable List
« Back